A 7-year-old boy from Tamil Nadu with β-thalassemia major presents with severe anemia (Hb 5.2 g/dL) and hepatosplenomegaly. He has received multiple transfusions over the past 3 years. Which drug is the first-line choice to prevent iron overload complications in this patient?